While CHK1 inhibitors have a wide cytotoxicity profile, leukemia cell lines were shown to be more sensitive to selective CHK1 inhibition (V158411 [Vernalis]) than lung and colon cancer cell lines (83). This evidence concerns the gene CHEK1 and malignant colon neoplasm.